Loing Estelle, Lamarque Elisabeth, Borel Magali
Lucas Meyer Cosmetics, IFF, Tour de la Cité, Québec, Canada (E.L.), Lucas Meyer Cosmetics, IFF, 31036 Toulouse Cedex 1 (E.L.), and Lucas Meyer Cosmetics, IFF, 91160 Champlan (M.B.), France.
J Cosmet Sci. 2017 Jan/Feb;68(1):107-113.
Dandruff is a scalp disorder characterized by flaking skin and itch of an excessive oily scalp skin. It affects 55% of the global youth and adult population. Seborrheic dermatitis is a similar scalp skin disorder with aggravated itchy rashes and flaking. Different factors are identified in the dandruff development: increased sebum production, uncontrolled fungal growth of strains and individual reaction to pro-inflammatory environment, and the susceptibility to trigger an immunological response. Using and models, we show that an extract dose dependently reduces lipid synthesis in sebocytes to a maximum of -43% (1% extract), and protects the epidermis from -induced morphological changes. extract also acts through innovative mechanisms involving regulations of defensins (human beta-defensins [hBD2] and hBD3) and toll-like receptor 2 involved in the immunological response of the skin. The anti-dandruff and sebum-regulating efficacy of extract (1.5%) was confirmed in a clinical study that mobilized 24 volunteers with dandruff and greasy scalp for 30 days. At the end of the study, nonadherent and adherent dandruffs were significantly ( < 0.0001) reduced in average by -54% and -48%, respectively. Using Sebumeter® measurements, scalp sebum production was inhibited by -67% ( < 0.0001) in average over baseline. In conclusion, extract offers a new innovative approach to dandruff reduction through immunomodulation of the skin response to invasion.
头皮屑是一种头皮疾病,其特征为皮肤片状剥落以及油性头皮皮肤过度瘙痒。它影响着全球55%的青年和成年人口。脂溢性皮炎是一种类似的头皮皮肤疾病,伴有加剧的瘙痒皮疹和片状剥落。在头皮屑的形成过程中发现了不同的因素:皮脂分泌增加、特定菌株的真菌生长失控、个体对促炎环境的反应以及引发免疫反应的易感性。使用[具体模型1]和[具体模型2]模型,我们发现[提取物名称]提取物剂量依赖性地将皮脂细胞中的脂质合成降低至最大-43%(1%提取物),并保护表皮免受[具体诱导因素]诱导的形态变化影响。[提取物名称]提取物还通过涉及调节参与皮肤免疫反应的防御素(人β-防御素[hBD2]和hBD3)和Toll样受体2的创新机制发挥作用。一项临床研究证实了[提取物名称]提取物(1.5%)的抗头皮屑和调节皮脂的功效,该研究动员了24名有头皮屑和油性头皮的志愿者参与30天。在研究结束时,非附着性和附着性头皮屑平均显著(<0.0001)减少了-54%和-48%。使用皮脂仪测量,头皮皮脂分泌平均比基线水平抑制了-67%(<0.0001)。总之,[提取物名称]提取物通过对皮肤对[具体侵袭因素]侵袭反应的免疫调节,为减少头皮屑提供了一种新的创新方法。